Faculty: Sundar Ganesan
Whenever regulatory authorities anywhere in the world perform an audit of a drug manufacturer, one of their most frequent findings remains the inadequate performance of the investigation of failures arises from OOS. Authorities expect stakeholders will carefully investigate failures to identify non-compliance, intervene and then evaluate the effectiveness of that intervention. Without adequate investigation and root cause analysis (RCA), those stakeholders cannot effectively identify and design successful interventions. In fact, organizations waste millions of dollars every year on ineffective interventions.
Many manufacturers run afoul of the FDA/EUGMP/ WHO over their corrective and preventive actions (CAPA) procedures, since CAPA can impact almost every area of your manufacturing operations, it’s crucial for all employees to understand at least the basics – the what, why and how. But boiling the complexities of Failures and in effective CAPA down the organizations into a severe regulatory non compliance level and resolve the issue can be a real challenge.
Why You Should Attend:
Current Regulators expectations is that “A firm’s primary goals in investigating a Failure incident should include both discovering its cause and ensuring it does not reoccur”.
This is the advanced and skill based training in specific subjects related to Out of specification (OOS) and related failures investigation and root cause analysis (RCA) –effective investigations to identify the actual, factual root cause and how to develop effective CAPA strategy to eliminate forever in good manufacturing processes and quality Control (QC) systems. This course details with current regulatory expectations on failures investigation and root cause analysis (RCA) with implementation of effective CAPA
Areas Covered in the Session :
Who Should Attend: